Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Nonmelanoma Skin Cancer and Related Disorders
  Follow Topic   Edit Search
Your search returned 46 results
from the time period: last 90 days.
Sort by Relevance / Date Group By Journal / No Grouping
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
... PubMed/MEDLINE, Web of Science, and EMBASE was conducted to identify articles published from 1960 to present that detail histology of initial biopsy and debulked tumor AbstractText: Fourteen studies, encompassing 2,565 cases of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) were included in the data extraction process.
Oncology (2)
Neoplasms (8), Carcinoma (2), Squamous Cell Carcinoma (1), more mentions
The New England journal of medicine
No summary available
Anti-Obesity and Weight Loss (2), Immune System Diseases (2), Neuroscience (1)
Pancytopenia (2), Carcinoma (1), Skin Diseases (1), more mentions
Journal of the American Academy of Dermatology
Tumor PD-L1 expression has been associated with poor outcome in a wide variety of cancers; however, data in cutaneous squamous cell carcinoma (cSCC) are scarce and conflicting AbstractText: To investigate the relationship of tumor PD-L1 expression with the clinicopathologic features and prognosis of ... Keyword: cutaneous squamous cell carcinoma.
Oncology (5)
Neoplasms (7), Squamous Cell Carcinoma (3), Head and Neck Neoplasms (1), more mentions
JAMA dermatology
AbstractText: Perineural invasion (PNI) in cutaneous squamous cell carcinoma (CSCC) has been associated with an increased risk of poor outcomes. Patients with PNI may present with clinical symptoms and/or radiologic evidence of PNI (clinical PNI [CPNI]), yet most patients are asymptomatic and PNI is often found on histologic examination (incidental PNI [IPNI.
Oncology (6), Dermatology (1)
Squamous Cell Carcinoma (2), Neoplasms (2), Neoplasm Invasiveness (1), more mentions
Diseases of the colon and rectum
... of the condition, studies concerning the management of patients with squamous cell carcinoma of the anus with distant metastasis are scarce... multidisciplinary treatment on overall survival among patients presenting with metastatic squamous cell carcinoma of the anus AbstractText: This was a retrospective study AbstractText ... Consecutive patients with histologically proven, newly diagnosed, or recurrent metastatic squamous cell carcinoma of the anus were included AbstractText: Study interventions included multimodal ...
Oncology (4)
Squamous Cell Carcinoma (5), Bone Neoplasms (1), Lung Neoplasms (1), more mentions
Gastroenterology
Abstract: Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of the 456,000 incident esophageal cancers each year... Keyword: Squamous cell carcinoma.
Oncology (1)
Squamous Cell Carcinoma (3), Esophageal Neoplasms (1), more mentions
Chest
This study tested the hypothesis that increasing time between diagnosis and lobectomy for stage IA squamous cell carcinoma (SCC) was associated with worse survival AbstractText: The association between timing of lobectomy and survival for patients with clinical stage IA SCC in the National Cancer Data Base (2006-2011) was assessed ...
Oncology (4)
Lung Neoplasms (3), Squamous Cell Carcinoma (2), Neoplasms (1), more mentions
Gastroenterology
Since the esophagus is easily accessible with endoscopy, early diagnosis and curative treatment of esophageal cancer is possible. However, diagnosis is often delayed because symptoms are not specific during early stages of tumor development. The onset of dysphagia is associated with advanced disease, and fewer than 15% of patients survive for 5 years. Population screening by endoscopy is not cost effective, but a number of alternative imaging and cell analysis technologies are under investigation. The ideal screening test should be inexpensive, well tolerated, and applicable to primary care. Over the last 10 years, significant progress has been made in endoscopic diagnosis and treatment of dysplasia (squamous and Barrett's), and early esophageal cancer using resection and ablation technologies supported by evidence from randomized controlled trials. We review the state-of-the-art technologies for early diagnosis and minimally invasive treatment, which together could reduce the burden of disease.
Oncology (3)
Esophageal Neoplasms (3), Squamous Cell Carcinoma (1), Neoplasms (1), more mentions
Gastroenterology
Abstract: Esophageal squamous cell carcinoma (ESCC) is a common malignancy without effective therapy. The exomes of more than 600 ESCCs have been sequenced in the last 4 years, and numerous key aberrations have been identified(1-4. Recently, researchers reported both inter- and intra-tumor heterogeneity(5, 6. Although these are interesting observations, their clinical implications are unclear due to ...
Oncology (1)
Squamous Cell Carcinoma (2), Neoplasms (2), Esophageal Neoplasms (1), more mentions
The Lancet. Oncology
AbstractText: Patients with platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck have few treatment options and ... label, phase 3 trial in patients with recurrent or metastatic squamous cell carcinoma of the head and neck who progressed within 6 months ... investigator's choice in patients with platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck.
Oncology (2)
Squamous Cell Carcinoma (5), Head and Neck Neoplasms (1), Neoplasms (1), more mentions
Journal of the American Academy of Dermatology
There have been concerns about the development of squamous cell carcinoma (SCC) in patients treated with this drug AbstractText: We sought ... Covariates including age, sex, history of previous nonmelanoma skin cancer, and number of visits per year were significantly associated with ... SCC when compared with standard surgical treatment of BCC Keyword: basal cell carcinoma.
Oncology (2)
Squamous Cell Carcinoma (3), Basal Cell Carcinoma (3), Skin Neoplasms (2), more mentions
Journal of the American Academy of Dermatology
Radiation therapy for nonmelanoma skin cancer, a cost comparison: 2016 coding changes to radiation therapy..
Oncology (2)
Skin Neoplasms (2), more mentions
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
AbstractText: Nonmelanoma skin cancers (NMSCs) of the ear are considered high risk... chart review of 649 consecutive patients treated with MMS at Mayo Clinic for primary cutaneous basal cell carcinomas (BCCs) or squamous cell carcinomas (SCCs) of the ear AbstractText: Nineteen percent of consecutively referred patients had NMSC of the ...
Squamous Cell Carcinoma (1), Basosquamous Carcinoma (1), Neoplasms (1), more mentions
JAMA dermatology
AbstractText: Protective effects of UV-B radiation against nonmelanoma skin cancer (NMSC) are exerted via signaling mechanisms involving the vitamin D ... who received a diagnosis of and were being treated for basal cell carcinoma or squamous cell carcinoma (cases) and 100 individuals who were receiving treatment of a condition other than skin cancer (controls) at the dermatology clinics at the Kirklin Clinic of ...
Oncology (7), Dermatology (1)
Skin Neoplasms (7), Sunburn (2), Squamous Cell Carcinoma (1), more mentions
Journal of the American Academy of Dermatology
... Voriconazole has previously been associated with increased risk for cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients... We evaluated the effect of voriconazole on the risk for nonmelanoma skin cancer (NMSC), including SCC and basal cell carcionoma, among those who ... risk specifically for SCC in the allogeneic HCT population Keyword: basal cell carcinoma... Keyword: nonmelanoma skin cancer.
Oncology (3)
Squamous Cell Carcinoma (2), Skin Neoplasms (2), Neoplasms (1), more mentions
The British journal of dermatology
Abstract: Nonmelanoma skin cancer (NMSC) comprises mainly basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC. The association between alcohol intake and NMSC has been inconclusive; therefore the objective of this study is to quantify the relationship between alcohol intake and NMSC using meta-analyses. A systematic literature search of PubMed and Embase was performed on 30 October 2016.
Oncology (2)
Skin Neoplasms (2), Squamous Cell Carcinoma (1), Basal Cell Carcinoma (1), more mentions
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
AbstractText: Epidermally limited nonmelanoma skin cancer (ELNMSC) (superficial basal cell carcinoma [SBCC] and squamous cell carcinoma in situ [SCCIS]) is common. Data on outcomes and patient satisfaction are lacking AbstractText: To examine treatment efficacy and satisfaction in ELNMSC patients AbstractText: Retrospective cohort study of adults with primary SBCC or SCCIS.
Oncology (2)
Skin Neoplasms (2), Squamous Cell Carcinoma (1), Neoplasms (1), more mentions
JAMA dermatology
Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial..
Basal Cell Carcinoma (2), more mentions
The British journal of dermatology
A new potential option for topical treatment of basal cell carcinoma?.
Basal Cell Carcinoma (2), more mentions
The British journal of dermatology
To examine which attributes of a non-invasive treatment for superficial BCC (sBCC) are valued by patients, a discrete choice experiment (DCE) was performed alongside a clinical trial in which methylaminolevulinate photodynamic therapy (MAL-PDT), 5-fluorouracil and imiquimod were compared.(1) Treatment options were described by the following attributes: effectiveness, cosmetic result, treatment process and side-effects. Effectiveness was defined as the probability that complete tumour clearance is achieved 12 months after treatment with levels of 75%,80%,85% and 90%.(2-4) This article is protected by copyright. All rights reserved.
Basal Cell Carcinoma (1), more mentions
1 2 3  | Next Page»